Correction to: Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson's disease.

Journal

Molecular neurodegeneration
ISSN: 1750-1326
Titre abrégé: Mol Neurodegener
Pays: England
ID NLM: 101266600

Informations de publication

Date de publication:
15 Jan 2020
Historique:
entrez: 16 1 2020
pubmed: 16 1 2020
medline: 16 1 2020
Statut: epublish

Résumé

The original article [1] contains an error in the y-axes of Fig. 8's sub-figures whereby 'CSF' is mistakenly mentioned instead of 'serum'.

Identifiants

DOI: 10.1186/s13024-019-0355-z PMID: 31937358 PMC: PMC6961314
pubmed: 31937358
doi: 10.1186/s13024-019-0355-z
pii: 10.1186/s13024-019-0355-z
pmc: PMC6961314
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

6

Commentaires et corrections

Type : ErratumFor

Références

Mol Neurodegener. 2019 Nov 8;14(1):40
pubmed: 31703585

Auteurs

Mylene Huebecker (M)

Department of Pharmacology, University of Oxford, Oxford, OX1 3QT, UK.

Elizabeth B Moloney (EB)

Neuroregeneration Institute, McLean Hospital / Harvard Medical School, Belmont, MA, 02478, USA.

Aarnoud C van der Spoel (AC)

Departments of Pediatrics and Biochemistry & Molecular Biology, Atlantic Research Centre, Dalhousie University, Halifax, NS, B3H 4R2, Canada.

David A Priestman (DA)

Department of Pharmacology, University of Oxford, Oxford, OX1 3QT, UK.

Ole Isacson (O)

Neuroregeneration Institute, McLean Hospital / Harvard Medical School, Belmont, MA, 02478, USA. isacson@hms.harvard.edu.

Penelope J Hallett (PJ)

Neuroregeneration Institute, McLean Hospital / Harvard Medical School, Belmont, MA, 02478, USA. phallett@mclean.harvard.edu.

Frances M Platt (FM)

Department of Pharmacology, University of Oxford, Oxford, OX1 3QT, UK. frances.platt@pharm.ox.ac.uk.

Classifications MeSH